Viewing nowCombinationEmpogad duo pills 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202302784 · Approved 2023.09.20 · Insurance code 651206240
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used alongside diet and exercise to help control blood sugar in adult patients with type 2 diabetes. It is particularly effective for patients whose blood sugar control is insufficient and is recommended to be used cautiously in those with cardiovascular disease. This medication supports diabetes management by improving blood sugar levels and helps enhance the overall health of the patient.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's existing metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their existing doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients 75 years of age or older, renal function and the risk of volume depletion should be taken into consideration.
This medication can cause a rare but life-threatening metabolic complication known as severe lactic acidosis, so patients with impaired kidney function or cardiopulmonary disease should exercise caution. The risk of hypoglycemia may occur when this medication is used in combination with other diabetes treatments; therefore, dose adjustments may be necessary when taken alongside insulin or sulfonylureas. Patients who are allergic to any ingredient included in this medication, have moderate or severe renal impairment, acute renal issues, or severe infections should not take this medication. Additionally, it is contraindicated in type 1 diabetes patients, those with acute or chronic metabolic acidosis, acute heart failure, or unstable heart failure, and patients scheduled for tests using radioactive iodine contrast. The use of this medication is not recommended during pregnancy or breastfeeding and is also not advised for children under the age of 18. Regular kidney function tests should be conducted during the course of taking this medication, especially for the elderly or those with reduced kidney function. In patients with a risk of fluid loss, such as dehydration, diarrhea, or vomiting, the use of this medication should be temporarily discontinued or carefully monitored. This medication may increase the risk of urinary tract infections and genital infections, so if infection symptoms appear, immediate consultation with healthcare providers is required. Long-term use may lead to vitamin B12 deficiency; therefore, it is advisable to regularly check vitamin levels through blood tests. Excessive alcohol consumption should be avoided during the course of taking this medication, as alcohol can increase the risk of lactic acidosis. Patients scheduled for surgery should discontinue this medication 48 hours before surgery and can resume once kidney function has returned to normal post-surgery. There is insufficient research on the effects of this medication on driving or operating machinery, so caution is required during its use. Overdose of this medication may lead to serious side effects such as lactic acidosis, so immediate medical attention is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safest to store it at room temperature between 1 to 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents degradation.
White, oval, biconvex film-coated tablet with a pink hue
Domestic use - 60 tablets/bottle, Domestic use - 30 tablets/bottle, Domestic use - 10 tablets/box [(10 tablets/PTP x1)], Domestic use - 60 tablets/box [(10 tablets/PTP x6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.